−20KRW
−3.88 BKRW
234.90 BKRW
86.95 M
About YUNGJIN PHARM
Sector
CEO
Gi-Soo Lee
Headquarters
Seoul
Website
Employees (FY)
624
Founded
1962
ISIN
KR7003520004
FIGI
BBG000BDQSK6
Yungjin Pharm. Co., Ltd. engages in the development, production, and distribution of pharmaceuticals. Its products include cephalosporin, antibiotics, drugs for the central nervous system, cardiovascular, endocrine system, urinary system, respiratory, anti-inflammatory and analgesics, anti-histamine, anti-fungal, total nutrition, vitamin and supplement, cosmetics, and tonic drinks. The company was founded on July 16, 19672 and is headquartered in Seoul, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 003520 is 2050.00 KRW — it has increased by 1.23% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange YUNGJIN PHARM stocks are traded under the ticker 003520.
YUNGJIN PHARM is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track YUNGJIN PHARM financials in yearly and quarterly reports right on TradingView.
Like other stocks, 003520 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade YUNGJIN PHARM stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 624.00 employees. See our rating of the largest employees — is YUNGJIN PHARM on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. YUNGJIN PHARM EBITDA is 11.81 B KRW, and current EBITDA margin is 5.03%. See more stats in YUNGJIN PHARM financial statements.